▶ 調査レポート

世界の汗腺炎掻爬治療市場:市場規模・現状・予測

• 英文タイトル:Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の汗腺炎掻爬治療市場:市場規模・現状・予測 / Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7295資料のイメージです。• レポートコード:QYR9N7295
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別(薬、手術、その他)、用途別(病院、診療所、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・汗腺炎掻爬治療の世界市場規模
・主要企業別市場シェア
・汗腺炎掻爬治療の世界市場規模:種類別(薬、手術、その他)
・汗腺炎掻爬治療の世界市場規模:用途別(病院、診療所、その他)
・汗腺炎掻爬治療のアメリカ市場規模(種類別、用途別)
・汗腺炎掻爬治療のヨーロッパ市場規模(種類別、用途別)
・汗腺炎掻爬治療の中国市場規模(種類別、用途別)
・汗腺炎掻爬治療の日本市場規模(種類別、用途別)
・汗腺炎掻爬治療の東南アジア市場規模(種類別、用途別)
・汗腺炎掻爬治療のインド市場規模(種類別、用途別)
・汗腺炎掻爬治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・汗腺炎掻爬治療の世界市場予測(2019年-2025年)
・汗腺炎掻爬治療の地域別市場予測(2019年-2025年)
...

Hidradenitis suppurativa is a rare, inflammatory skin condition that begins as small and painful pimples on the skin. This medical condition is most common between the ages of 20-40 years. Prevalence of hidradenitis suppurativa is three times more common in females than in males.Considering the global scenario of the market, North America holds the largest market share due to various factors such as increasing cases of skin diseases and related medical complications.
In 2018, the global Hidradenitis Suppurativa Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hidradenitis Suppurativa Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hidradenitis Suppurativa Treatment development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Allergan
AstraZeneca

Market segment by Type, the product can be split into
Medications
Surgery
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hidradenitis Suppurativa Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hidradenitis Suppurativa Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hidradenitis Suppurativa Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Medications
1.4.3 Surgery
1.4.4 Others
1.5 Market by Application
1.5.1 Global Hidradenitis Suppurativa Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hidradenitis Suppurativa Treatment Market Size
2.2 Hidradenitis Suppurativa Treatment Growth Trends by Regions
2.2.1 Hidradenitis Suppurativa Treatment Market Size by Regions (2014-2025)
2.2.2 Hidradenitis Suppurativa Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hidradenitis Suppurativa Treatment Market Size by Manufacturers
3.1.1 Global Hidradenitis Suppurativa Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hidradenitis Suppurativa Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hidradenitis Suppurativa Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hidradenitis Suppurativa Treatment Key Players Head office and Area Served
3.3 Key Players Hidradenitis Suppurativa Treatment Product/Solution/Service
3.4 Date of Enter into Hidradenitis Suppurativa Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019)
4.2 Global Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Hidradenitis Suppurativa Treatment Market Size (2014-2019)
5.2 Hidradenitis Suppurativa Treatment Key Players in United States
5.3 United States Hidradenitis Suppurativa Treatment Market Size by Type
5.4 United States Hidradenitis Suppurativa Treatment Market Size by Application

6 Europe
6.1 Europe Hidradenitis Suppurativa Treatment Market Size (2014-2019)
6.2 Hidradenitis Suppurativa Treatment Key Players in Europe
6.3 Europe Hidradenitis Suppurativa Treatment Market Size by Type
6.4 Europe Hidradenitis Suppurativa Treatment Market Size by Application

7 China
7.1 China Hidradenitis Suppurativa Treatment Market Size (2014-2019)
7.2 Hidradenitis Suppurativa Treatment Key Players in China
7.3 China Hidradenitis Suppurativa Treatment Market Size by Type
7.4 China Hidradenitis Suppurativa Treatment Market Size by Application

8 Japan
8.1 Japan Hidradenitis Suppurativa Treatment Market Size (2014-2019)
8.2 Hidradenitis Suppurativa Treatment Key Players in Japan
8.3 Japan Hidradenitis Suppurativa Treatment Market Size by Type
8.4 Japan Hidradenitis Suppurativa Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hidradenitis Suppurativa Treatment Market Size (2014-2019)
9.2 Hidradenitis Suppurativa Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Type
9.4 Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Application

10 India
10.1 India Hidradenitis Suppurativa Treatment Market Size (2014-2019)
10.2 Hidradenitis Suppurativa Treatment Key Players in India
10.3 India Hidradenitis Suppurativa Treatment Market Size by Type
10.4 India Hidradenitis Suppurativa Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Hidradenitis Suppurativa Treatment Market Size (2014-2019)
11.2 Hidradenitis Suppurativa Treatment Key Players in Central & South America
11.3 Central & South America Hidradenitis Suppurativa Treatment Market Size by Type
11.4 Central & South America Hidradenitis Suppurativa Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hidradenitis Suppurativa Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hidradenitis Suppurativa Treatment Introduction
12.2.4 Johnson & Johnson Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hidradenitis Suppurativa Treatment Introduction
12.3.4 Merck Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hidradenitis Suppurativa Treatment Introduction
12.4.4 Pfizer Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hidradenitis Suppurativa Treatment Introduction
12.5.4 AbbVie Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.5.5 AbbVie Recent Development
12.6 Allergan
12.6.1 Allergan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hidradenitis Suppurativa Treatment Introduction
12.6.4 Allergan Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.6.5 Allergan Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hidradenitis Suppurativa Treatment Introduction
12.7.4 AstraZeneca Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)
12.7.5 AstraZeneca Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Hidradenitis Suppurativa Treatment Key Market Segments
Table Key Players Hidradenitis Suppurativa Treatment Covered
Table Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hidradenitis Suppurativa Treatment Market Size Market Share by Type 2014-2025
Figure Medications Figures
Table Key Players of Medications
Figure Surgery Figures
Table Key Players of Surgery
Figure Others Figures
Table Key Players of Others
Table Global Hidradenitis Suppurativa Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Hidradenitis Suppurativa Treatment Report Years Considered
Table Global Hidradenitis Suppurativa Treatment Market Size 2014-2025 (Million US$)
Figure Global Hidradenitis Suppurativa Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hidradenitis Suppurativa Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Hidradenitis Suppurativa Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Hidradenitis Suppurativa Treatment Market Share by Regions 2014-2019
Figure Global Hidradenitis Suppurativa Treatment Market Share by Regions 2014-2019
Figure Global Hidradenitis Suppurativa Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Hidradenitis Suppurativa Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hidradenitis Suppurativa Treatment Market Share by Manufacturers (2014-2019)
Figure Global Hidradenitis Suppurativa Treatment Market Share by Manufacturers in 2018
Table Global Hidradenitis Suppurativa Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hidradenitis Suppurativa Treatment Product/Solution/Service
Table Date of Enter into Hidradenitis Suppurativa Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Hidradenitis Suppurativa Treatment Market Size Share by Type (2014-2019)
Figure Global Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2014-2019)
Table Global Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Hidradenitis Suppurativa Treatment Market Size Share by Application (2014-2019)
Figure Global Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2014-2019)
Figure Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application in 2018
Figure United States Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table United States Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table United States Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Figure Europe Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table Europe Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table Europe Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Figure China Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table China Hidradenitis Suppurativa Treatment Market Size by Type (2014-20189) (Million US$)
Table China Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table China Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table China Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Figure Japan Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table Japan Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table Japan Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Figure India Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table India Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table India Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table India Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table India Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Figure Central & South America Hidradenitis Suppurativa Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hidradenitis Suppurativa Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hidradenitis Suppurativa Treatment Market Share (2018-2019)
Table Central & South America Hidradenitis Suppurativa Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hidradenitis Suppurativa Treatment Market Share by Type (2014-2019)
Table Central & South America Hidradenitis Suppurativa Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hidradenitis Suppurativa Treatment Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Allergan Company Details
Table Allergan Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table Allergan Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Hidradenitis Suppurativa Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Global Hidradenitis Suppurativa Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Hidradenitis Suppurativa Treatment Market Size Share by Regions (2019-2025)
Figure Global Hidradenitis Suppurativa Treatment Market Size Share by Regions in 2025
Figure United States Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hidradenitis Suppurativa Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Hidradenitis Suppurativa Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Hidradenitis Suppurativa Treatment Market Size by Product (2019-2025)
Figure Global Hidradenitis Suppurativa Treatment Market Size by Product in 2025
Table Global Hidradenitis Suppurativa Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Hidradenitis Suppurativa Treatment Market Size by Application (2019-2025)
Figure Global Hidradenitis Suppurativa Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources